1429P Pathological regression in patients with microsatellite instability (MSI) receiving perioperative atezolizumab in combination with FLOT vs. FLOT alone for resectable esophagogastric adenocarcinoma: Results from the DANTE trial of the German Gastric Group at the AIO and SAKK

S-E. Al-Batran, Sylvie Lorenzen, Nils Homann, Peter Thuss‐Patience, Michael Schenk, Udo Lindig, A. Kretzschmar, Vera Heuer, Eray Goekkurt, Georg Martin Haag, Jorge Riera Knorrenschild, Claus Bolling, R. D. Hofheinz, Alexander Siebenhuener, Natsumi Irahara, Christina Kopp, Lisa Waberer, Claudia Pauligk, T.O. Götze, Timo Gaiser